DEPO-MEDROL

This brand name is authorized in United States. It is also authorized in Australia, Brazil, Canada, Croatia, Ecuador, Estonia, Finland, France, Hong Kong SAR China, Israel, Japan, Mexico, Netherlands, New Zealand, Poland, Tunisia, Turkey.

Active ingredients

The drug DEPO-MEDROL contains one active pharmaceutical ingredient (API):

1	Methylprednisolone UNII 43502P7F0P - METHYLPREDNISOLONE ACETATE
	Methylprednisolone is a synthetic glucocorticoid and a methyl derivative of prednisolone. Methylprednisolone is a potent anti-inflammatory agent with the capacity to profoundly inhibit the immune system.
	Read more about Methylprednisolone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
DEPO-MEDROL Suspension for injection	MPI, EU: SmPC	Medicines and Medical Devices Safety Authority (NZ)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
H02AB04	Methylprednisolone	H Systemic hormonal preparations, excl. Sex hormones and insulins → H02 Corticosteroids for systemic use → H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN → H02AB Glucocorticoids
Discover more medicines within H02AB04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	1928L, 5148Y
BR	Câmara de Regulação do Mercado de Medicamentos	522718040079917
CA	Health Products and Food Branch	00030759, 00030767, 01934325, 01934333, 01934341
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	360560612
EE	Ravimiamet	1009190, 1065495, 1065507, 1309597, 1309609
FI	Lääkealan turvallisuus- ja kehittämiskeskus	189514, 189522
FR	Base de données publique des médicaments	64085814
HK	Department of Health Drug Office	00490
HR	Agencija za lijekove i medicinske proizvode	HR-H-890794207
IL	מִשְׂרַד הַבְּרִיאוּת	35, 36, 37
JP	医薬品医療機器総合機構	2456402C1044, 2456402C2040
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	55041
NL	Z-Index G-Standaard	14040441, 14040468
NL	Z-Index G-Standaard, PRK	2267, 4839
NZ	Medicines and Medical Devices Safety Authority	1130
PL	Rejestru Produktów Leczniczych	100192605, 100352530, 100437082
TN	Direction de la Pharmacie et du Médicament	8013051
TR	İlaç ve Tıbbi Cihaz Kurumu	8681308771063
US	FDA, National Drug Code	0009-0274, 0009-0280, 0009-0306, 0009-3073, 0009-3475, 50090-0312, 70518-0516, 70518-2148, 76420-081